Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
Phase of Trial: Phase I/II
Latest Information Update: 04 Dec 2018
Price : $35 *
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Brain metastases; Breast cancer
- Focus Therapeutic Use
- 26 Nov 2018 Status changed from not yet recruiting to recruiting.
- 09 Aug 2018 Planned initiation date changed from 30 Jun 2018 to 30 Sep 2018.
- 30 Apr 2018 Planned initiation date changed from 30 Mar 2018 to 30 Jun 2018.